John M. Burke, PhD President, CEO and Co-founder of Applied BioMath will present a talk on "Quantitative Systems Approaches in Inflammation to Enable Decision Making in Early Discovery and Clinical Trials" at the "Quantitative Systems Pharmacology: Progress Towards Integration into Drug Discovery and Development" conference on May 26, 2015 at the New York Academy of Sciences.  This symposium highlights advances in QSP applications in the continuum from preclinical exploration to clinical research and includes academic, government, and industry perspectives on the benefits and challenges of full adoption. Case studies from several therapeutic areas will be presented with applications to drug safety, efficacy, and precision medicine.

Other speakers include researchers from Pfizer Inc., Merck & Co., Johnson & Johnson, US Food and Drug Administration (FDA), Harvard Medical School, and Hamner-UNC Institute for Drug Safety Sciences.